Current capacity and gaps in viral vector manufacturing: a survey of centers associated with CTIWP of EBMT, NXTGEN-hightech, DARE-NL, T2EVOLVE, and GoCART coalition
Year: 2025
Type: letter
Language: en
Topic: Virus-based gene therapy research
Authors and affiliations:
raw_author_name: Ganesh Ramesh
raw_affiliation_strings: University Medical Center Utrecht, Utrecht, The Netherlands
raw_author_name: Zsolt Sebestyen
raw_affiliation_strings: University Medical Center Utrecht, Utrecht, The Netherlands
raw_author_name: Anil Kumar Deshantri
raw_affiliation_strings: University Medical Center Utrecht, Utrecht, The Netherlands
raw_author_name: Simone Punt
raw_affiliation_strings: University Medical Center Utrecht, Utrecht, The Netherlands
raw_author_name: Emma Martinez Sanchez
raw_affiliation_strings: University Medical Center Utrecht, Utrecht, The Netherlands
raw_author_name: Jesus Fernandez-Sojo
raw_affiliation_strings: Servei de Terapia ce·llular, Banc de Sang i Teixits, Barcelona, Spain; Grup de Medicina Transfusional, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
Servei de Terapia ce·llular, Banc de Sang i Teixits, Barcelona, Spain
Grup de Medicina Transfusional, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
raw_author_name: Sergi Querol
raw_affiliation_strings: Spanish Bone Marrow Registry (REDMO), Barcelona, Spain
raw_author_name: Michael Hudecek
raw_affiliation_strings: Fraunhofer-Institut für Zelltherapie und Immunologie (IZI), Außenstelle Zelluläre Immuntherapie, Würzburg, Germany
Medizinische Klinik und Poliklinik II und Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik II, Universitätsklinikum Würzburg, Würzburg, Germany
raw_author_name: Carmen Sanges
raw_affiliation_strings: Fraunhofer-Institut für Zelltherapie und Immunologie (IZI), Außenstelle Zelluläre Immuntherapie, Würzburg, Germany
raw_author_name: Ruud Das
raw_affiliation_strings: Scinus Cell Expansion Netherlands BV, Zeist, The Netherlands
raw_author_name: Aiko Ballardini
raw_affiliation_strings: Innovation Center for Advanced Therapies, UMCU, Utrecht, The Netherlands
raw_author_name: Cristina Eguizabal
raw_affiliation_strings: Advanced Therapies Unit, Basque Center for Blood Transfusion and Human Tissues, Galdakao, Spain; Cell Therapy, Stem Cells and Tissues, Biobizkaia Health Research Center, Barakaldo, Spain
Cell Therapy, Stem Cells and Tissues, Biobizkaia Health Research Center, Barakaldo, Spain
Advanced Therapies Unit, Basque Center for Blood Transfusion and Human Tissues, Galdakao, Spain
raw_author_name: Dirk Geerts
raw_affiliation_strings: Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands
raw_author_name: Ardeshir Ghavamzadeh
raw_affiliation_strings: Motamed Cancer Institute, Academic Center for Education, Culture and Research, Tehran, Iran
raw_author_name: Virginia Escamilla Gómez
raw_affiliation_strings: Hospital Universitario Virgen Del Rocío, Seville, Spain
raw_author_name: Manel Juan
raw_affiliation_strings: Hospital Clínic de Barcelona, Barcelona, Spain
raw_author_name: Thomas Stauffer Larsen
raw_affiliation_strings: Odense University Hospital, Odense, Denmark
raw_author_name: Petr Lesný
raw_affiliation_strings: Institute of Hematology and Blood Transfusion, Prague, Czech Republic
raw_author_name: Daniel Lysák
raw_affiliation_strings: University Hospital Pilsen, Pilsen, Czechia
raw_author_name: Mirko Müller
raw_affiliation_strings: Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany
raw_author_name: Unai Perpiñá
raw_affiliation_strings: August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036, Barcelona, Spain
Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences; Creatio, Production and Validation Center of Advanced Therapies; and Institute of Neurosciences, University of Barcelona, Barcelona, Spain
Institute of Neurosciences, University of Barcelona, Barcelona, Spain
Laboratory of Stem Cells and Regenerative Medicine, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences
Creatio, Production and Validation Center of Advanced Therapies
raw_author_name: Sofieke de Wilde
raw_affiliation_strings: Erasmus Medical Center, Rotterdam, The Netherlands
raw_author_name: Florent Malard
raw_affiliation_strings: Hôpital Saint Antoine, AP-HP, Paris, France
On behalf of Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT, Paris, France
raw_author_name: Jorinde Hoogenboom
raw_affiliation_strings: EBMT Leiden Study Unit, Leiden, The Netherlands
On behalf of Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT, Leiden, The Netherlands
raw_author_name: Jarl Mooyaart
raw_affiliation_strings: EBMT Leiden Study Unit, Leiden, The Netherlands
On behalf of Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT, Leiden, The Netherlands
raw_author_name: Annalisa Ruggeri
raw_affiliation_strings: On behalf of Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT, Milano, Italy
San Raffaele Scientific Institute, Hematology and Bone Marrow Transplantation Unit, Milan, Italy
raw_author_name: Trudy Straetemans
raw_affiliation_strings: University Medical Center Utrecht, Utrecht, The Netherlands
raw_author_name: Jurgen Kuball
raw_affiliation_strings: On behalf of Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT, Utrecht, The Netherlands. J.H.E.Kuball@umcutrecht.nl
University Medical Center Utrecht, Utrecht, The Netherlands. J.H.E.Kuball@umcutrecht.nl
On behalf of Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT, Utrecht, The Netherlands